earnings
confidence high
sentiment negative
materiality 0.75
Ginkgo Q3 revenue $39M (-56% YoY); net loss $81M; reaffirms FY guide $167-187M
Ginkgo Bioworks Holdings, Inc.
2025-Q3 EPS reported
-$4.22
revenue$136,759,000
- Total revenue $39M, down 56% YoY; prior year had $45M non-cash deferred revenue; ex that, down 11%.
- GAAP net loss $81M vs $56M prior; Adjusted EBITDA loss $56M vs $20M.
- Reaffirms FY25 revenue $167-187M; Cell Engineering $117-137M; Biosecurity at least $40M.
- Cash & securities $462M; expands autonomous lab; Bayer partnership extended, BARDA contract up to $22.2M.
- Cell Engineering revenue $29M (-61% YoY); Biosecurity $9M ($14M prior).
item 2.02item 9.01